Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1261)	12/21/1998 9:01:00 PM
From: Sonki	Respond to of 1722

Merck & Co (MRK) & BMY > > > AXYS PHARMACEUTICALS INC and MERCK & CO have agreed to extend their > collaboration on the development of a molecule inhibitor for the > treatment of osteoporosis, Axys said. In November 1996, Axys signed a > two-year collaboration pact with Merck to develop small inhibitors of > cathepsin K, a cysteine protease target that is believed to play a > role in osteoporosis. Axys has research collaborations with several > pharmaceutical companies covering a wide range of therapeutic areas, > including respiratory, cardiovascular and infectious diseases. .............. Bristol Myers Squibb (BMY) > > > SIBIA NEUROSCIENCES INC said that a jury had awarded the company $18 > mln in damages in its patent infringement suit against CADUS > PHARMACEUTICAL CORP. SIBIA said that on Dec. 18, a jury in U.S. > District Court for the Southern District of California found that the > methods used by Cadus infringed all 11 claims of the patent asserted > by SIBIA and that the patent was valid and enforceable. The company > said the jury found that Cadus' collaborators, BRISTOL-MYERS SQUIBB CO > and SMITHKLN BEECHAM PLC, directly infringed SIBIA's patent and that > Cadus had induced and further contributed to infringement of SIBIA's > patent by Bristol-Myers Squibb and SmithKline Beecham. (Reuters 10:54 > (Reuters 07:41 AM ET 12/21/98)